The estimated Net Worth of Walter S Woltosz is at least $182 Million dollars as of 26 February 2018. Mr. Woltosz owns over 18,500 units of Simulations Plus stock worth over $179,894,474 and over the last 19 years he sold SLP stock worth over $1,832,772. In addition, he makes $124,765 as Chairman of the Board at Simulations Plus.
Sign up
Mr. Woltosz SLP stock SEC Form 4 insiders trading
Walter has made over 7 trades of the Simulations Plus stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 18,500 units of SLP stock worth $298,405 on 26 February 2018.
The largest trade he's ever made was selling 58,181 units of Simulations Plus stock on 29 January 2016 worth over $655,700. On average, Walter trades about 5,795 units every 80 days since 2005. As of 26 February 2018 he still owns at least 5,482,916 units of Simulations Plus stock.
You can see the complete history of Mr. Woltosz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Walter Woltosz biography
Walter S. Woltosz serves as Chairman of the Board of the Company. Mr. WOLTOSZ is a co-founder of the Company and has served as its Chief Executive Officer until June 26, 2018 and as Chairman of the Board since its incorporation in July 1996. Mr. Woltosz’s knowledge of the industry and his 22 years of experience running Simulations Plus makes him a qualified candidate for the Board.
What is the salary of Walter Woltosz?
As the Chairman of the Board of Simulations Plus, the total compensation of Walter Woltosz at Simulations Plus is $124,765. There are 13 executives at Simulations Plus getting paid more, with Shawn M. O'Connor having the highest compensation of $544,231.
How old is Walter Woltosz?
Walter Woltosz is 74, he's been the Chairman of the Board of Simulations Plus since 2018. There are 1 older and 13 younger executives at Simulations Plus. The oldest executive at Simulations Plus Inc. is Walter S. Woltosz M.A.S., M.S., 76, who is the Co-Founder & Chairman.
What's Walter Woltosz's mailing address?
Walter's mailing address filed with the SEC is 42505 10TH ST. WEST, , LANCASTER, CA, 93534.
Insiders trading at Simulations Plus
Over the last 20 years, insiders at Simulations Plus have traded over $70,055,940 worth of Simulations Plus stock and bought 24,000 units worth $1,395,840 . The most active insiders traders include Walter Swoltosz Virginia E ..., Walter S Woltosz, and Momoko A Beran. On average, Simulations Plus executives and independent directors trade stock every 37 days with the average trade being worth of $571,025. The most recent stock trade was executed by Jill Fiedler Kelly on 9 September 2024, trading 2,250 units of SLP stock currently worth $21,848.
What does Simulations Plus do?
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
What does Simulations Plus's logo look like?
Complete history of Mr. Woltosz stock trades at Simulations Plus
Simulations Plus executives and stock owners
Simulations Plus executives and other stock owners filed with the SEC include:
-
Shawn M. O'Connor,
Chief Exec. Officer -
Shawn O'Connor,
Chief Executive Officer -
William Frederick,
CFO & Sec. -
John DiBella,
President, Lancaster Division -
John Anthony DiBella M.S.,
Pres of Lancaster Division -
Thaddeus Grasela,
Senior Advisory Capacity -
John Kneisel,
Chief Financial Officer -
Jill Fiedler-Kelly M.S., MS,
Pres of Cognigen Division -
Dr. Brett A. Howell Ph.D.,
Pres of DILIsym Services, Inc -
Dr. Brett A. Howell,
Pres of DILIsym Services, Inc -
John Paglia,
Independent Director -
Daniel Weiner,
Independent Director -
David Ralph,
Independent Director -
Walter Woltosz,
Chairman of the Board -
Walter S. Woltosz M.A.S., M.S.,
Co-Founder & Chairman -
Lisa LaVange,
Independent Director -
Renee Bouche,
IR Contact Officer -
Jill Fiedler-Kelly,
President - Cognigen division -
Dr. Scott Q. Siler,
Chief Scientific Officer of DILIsym Services, Inc -
Lindsay Luke,
Exec. Director of HR -
Arlene Padron,
Corp. Director of Marketing -
Viera Lukacova Ph.D.,
Chief Scientific Officer -
Argenio David Z D,
Director -
Brett Howell,
Business Unit President -
Steven Chang,
President, Immunetrics -
William W Frederick,
CFO -
Walter Swoltosz Virginia E ...,
-
Walter S Woltosz,
Director -
Richard R Weiss,
Director -
Momoko A Beran,
Chief Financial Officer -
Harold Wayne Rosenberger,
Director -
Jeffrey A Dahlen,
VP, Research & Development -
Virginia E Woltosz,
Secretary/Treasurer -
Ronald F Creeley,
VP Marketing & Sales -
Daniel Szot,
Chief Revenue Officer -
Sharlene Evans,
Director